The Business Brew cover image

Randy Baron - International Truffle Hunting

The Business Brew

00:00

Is Rhenolytics Trying to Cure Kidney Disease?

The two public companies in the space are Davida and Forzanias, maybe 20 billion in market cap between them, and they're dialysis companies. And on the other side of it is a company called Read Analytics that's basically giving the diagnostic. Bill: I've got a tire company investment. Maybe that's a derivative, more downforce on cars. Yeah, we'll do part two. But the other part of the unholy trinity that I'm known for is a stock called Rhenolytics, okay? This is a company that is trying to cure kidney disease.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app